Relay Therapeutics Stock Market Value
| RLAY Stock | USD 4.86 0.11 2.32% |
| Symbol | Relay |
Relay Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Relay Therapeutics. If investors know Relay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Relay Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.61) | Revenue Per Share 0.076 | Quarterly Revenue Growth 43.279 | Return On Assets (0.27) | Return On Equity (0.43) |
The market value of Relay Therapeutics is measured differently than its book value, which is the value of Relay that is recorded on the company's balance sheet. Investors also form their own opinion of Relay Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Relay Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Relay Therapeutics' market value can be influenced by many factors that don't directly affect Relay Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Relay Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relay Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relay Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Relay Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Relay Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Relay Therapeutics.
| 01/31/2024 |
| 11/26/2024 |
If you would invest 0.00 in Relay Therapeutics on January 31, 2024 and sell it all today you would earn a total of 0.00 from holding Relay Therapeutics or generate 0.0% return on investment in Relay Therapeutics over 300 days. Relay Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company More
Relay Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Relay Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Relay Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 66.18 | |||
| Value At Risk | (6.29) | |||
| Potential Upside | 4.82 |
Relay Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Relay Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Relay Therapeutics' standard deviation. In reality, there are many statistical measures that can use Relay Therapeutics historical prices to predict the future Relay Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (1.54) | |||
| Treynor Ratio | (0.1) |
Relay Therapeutics Backtested Returns
Relay Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0406, which implies the firm had a -0.0406% return per unit of risk over the last 3 months. Relay Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Relay Therapeutics' Risk Adjusted Performance of (0.03), variance of 55.32, and Coefficient Of Variation of (1,997) to confirm the risk estimate we provide. The company holds a Beta of 3.89, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Relay Therapeutics will likely underperform. At this point, Relay Therapeutics has a negative expected return of -0.31%. Please make sure to check Relay Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Relay Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.53 |
Modest predictability
Relay Therapeutics has modest predictability. Overlapping area represents the amount of predictability between Relay Therapeutics time series from 31st of January 2024 to 29th of June 2024 and 29th of June 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Relay Therapeutics price movement. The serial correlation of 0.53 indicates that about 53.0% of current Relay Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.53 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 1.17 |
Relay Therapeutics lagged returns against current returns
Autocorrelation, which is Relay Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Relay Therapeutics' stock expected returns. We can calculate the autocorrelation of Relay Therapeutics returns to help us make a trade decision. For example, suppose you find that Relay Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Relay Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Relay Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Relay Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Relay Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Relay Therapeutics Lagged Returns
When evaluating Relay Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Relay Therapeutics stock have on its future price. Relay Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Relay Therapeutics autocorrelation shows the relationship between Relay Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Relay Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Relay Stock Analysis
When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.